Home
About
Overview
Sharing Data
ORCID
Help
History (70)
Anticoagulation Timing in Cardioembolic Stroke and Recurrent Event Risk.
Examining racial/ethnic inequities in treatment participation among perinatal individuals with depression.
Mapping the genetic landscape establishing a tumor immune microenvironment favorable for anti-PD-1 response in mice and humans.
Repeat presentation for middle aortic syndrome 18?years after original repair.
Challenges of Cellular Therapy During the COVID-19 Pandemic.
See All 70 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Challenges of Cellular Therapy During the COVID-19 Pandemic.
Sahu KK, Ailawadhi S, Malvik N, Cerny J. Challenges of Cellular Therapy During the COVID-19 Pandemic. Adv Exp Med Biol. 2021; 1318:657-672.
View in:
PubMed
subject areas
Cell- and Tissue-Based Therapy
Hematopoietic Stem Cell Transplantation
Humans
Immunotherapy, Adoptive
Pandemics
authors with profiles
Jan Cerny MD, PhD